New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
Oncology January 30,2024
Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
Oncology January 30,2024
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Oncology January 30,2024
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Oncology January 30,2024
Researchers identify protein linked to heart failure in chemo patients

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called
Oncology January 30,2024
Researchers identify protein linked to heart failure in chemo patients

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called
Oncology January 30,2024
An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong
Oncology January 30,2024
An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong
Oncology January 30,2024
Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right
Oncology January 30,2024
Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right
Oncology January 30,2024
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Oncology January 30,2024
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Oncology January 30,2024
One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc
Oncology January 30,2024
One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc
Oncology January 30,2024
Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for yea
Oncology January 30,2024
Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for yea
Oncology January 30,2024
Researchers identify potential gene marker for treating pancreatic cancer

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre
Oncology January 30,2024
Researchers identify potential gene marker for treating pancreatic cancer

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre
Oncology January 30,2024
Study finds new, unexpected mechanism of cancer cell spread

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu
Oncology January 30,2024
Study finds new, unexpected mechanism of cancer cell spread

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com